Citation: | FU Yan-jie, SUN Li-quan, FAN Xin-yuan, LIU Cong, YAO Guo-wei, LUO Ai-qin. Improvement in synthesis of 3'-N-demethylazithromycin and its derivatives[J].JOURNAL OF BEIJING INSTITUTE OF TECHNOLOGY, 2013, 22(1): 130-134. |
[1] |
Treadway G. Azithromycin: a new 15-membered macrolide[J]. TheJournal of Antibiotics, 2001, 54: 70-76.
|
[2] |
Lode H, Borner K, Koeppe P, et al. Azithromycin—review of key chemical, phannacokinetic and microbiological features[J]. Journal of Antimicrobial Chemotherapy, 1996, 37: 1-8.
|
[3] |
Kiran M M, Gokul L P, Mangesh B C, et al. A process for preparing 6,9-imino ether: WO2007015265[P]. 2007-02-08.
|
[4] |
Immaculada B, Victor C, Jose D, et al. Macrolide intermediates: WO0027856[P]. 2000-05-18.
|
[5] |
Wilkening R R, Ratcliffe R W, Doss G A, et al. Novel transannular Beckmann rearrangement of azalide iminoethers[J].Tetreahedron, 1997, 53(50): 16923-16944.
|
[6] |
Miguel B J, Rodrigo J C, Fernando L O. Synthesis of 9-deoxo-9a-aza- 9a-homoerythromycin A 11, 12-hydrogen borate and azithromycin 11,12-hydrogen borate: a new procedure to obtain azithromycin dihydrate[J]. Journal of Organic Chemistry, 1997, 62(21): 7479-7481.
|
[7] |
European Directorate for the Quality of Medicines. Europeanpharmacopoeia 6.0[S]. Norwich: TSO Publishing Solution, 2007: 1238-1240.
|
[8] |
The United Stated Pharmacopeia Convention. The United States pharmacopoeia, 32th edition[S]. Maryland: U.S.P. Convention, 2007: 1613.
|
[9] |
Anjan C, Baban S Y, Sambhaji J J, et al. Macrolide derivatives as antibacterial agents: WO2008111020[P].2008-09-18.
|
[10] |
Ashoke B, Duffy E M, Kanyo Z F, et al. Macrolide compounds and methods of making and using the same: WO2008143730[P]. 2008-11-27.
|
[11] |
Albert C, Jose D, Rafael G, et al.Derivatives of azithromycin: WO2004092736[P]. 2004-10-28.
|